CIT-013

DRUG2 trials

Sponsors

Citryll B.V.

Conditions

Hidradenitis SuppurativaModerately Active Rheumatoid Arthritis

Phase 2

A Phase IIa Double-Blind, Randomized, Parallel-Arm, Placebo-Controlled Trial To Investigate The Effects Of Three Dose Levels Of CIT-013 On Disease Activity In Patients With Moderately Active Rheumatoid Arthritis.

RecruitingCTIS2024-517356-35-00

Citryll B.V.Moderately Active Rheumatoid Arthritis

Start: 2025-07-29Target: 88Updated: 2026-01-27

A Phase 2a double blind, randomized, parallel arm, placebo-controlled trial to investigate the effects of two dose levels of CIT-013 on disease activity in patients with Hidradenitis Suppurativa (HS)

RecruitingCTIS2025-521684-12-00

Citryll B.V.Hidradenitis Suppurativa

Start: 2026-01-13Target: 64Updated: 2025-10-15